vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Caledonia Mining Corp Plc (CMCL). Click either name above to swap in a different company.

Caledonia Mining Corp Plc is the larger business by last-quarter revenue ($46.9M vs $39.8M, roughly 1.2× Carter Bankshares, Inc.). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs 13.8%). Over the past eight quarters, Caledonia Mining Corp Plc's revenue compounded faster (17.1% CAGR vs 9.1%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.

CARE vs CMCL — Head-to-Head

Bigger by revenue
CMCL
CMCL
1.2× larger
CMCL
$46.9M
$39.8M
CARE
Growing faster (revenue YoY)
CARE
CARE
+1.6% gap
CARE
15.4%
13.8%
CMCL
Faster 2-yr revenue CAGR
CMCL
CMCL
Annualised
CMCL
17.1%
9.1%
CARE

Income Statement — Q4 FY2025 vs Q3 FY2024

Metric
CARE
CARE
CMCL
CMCL
Revenue
$39.8M
$46.9M
Net Profit
$3.3M
Gross Margin
41.2%
Operating Margin
27.8%
18.6%
Net Margin
7.0%
Revenue YoY
15.4%
13.8%
Net Profit YoY
-33.3%
EPS (diluted)
$0.38
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
CMCL
CMCL
Q4 25
$39.8M
Q3 25
$39.1M
Q2 25
$37.3M
Q1 25
$37.0M
Q4 24
$34.5M
Q3 24
$34.2M
$46.9M
Q2 24
$33.6M
$50.1M
Q1 24
$33.5M
$38.5M
Net Profit
CARE
CARE
CMCL
CMCL
Q4 25
Q3 25
$5.4M
Q2 25
$8.5M
Q1 25
$9.0M
Q4 24
Q3 24
$5.6M
$3.3M
Q2 24
$4.8M
$10.2M
Q1 24
$5.8M
$2.1M
Gross Margin
CARE
CARE
CMCL
CMCL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
41.2%
Q2 24
45.8%
Q1 24
35.9%
Operating Margin
CARE
CARE
CMCL
CMCL
Q4 25
27.8%
Q3 25
18.3%
Q2 25
28.5%
Q1 25
30.1%
Q4 24
31.0%
Q3 24
20.5%
18.6%
Q2 24
17.6%
32.2%
Q1 24
21.6%
13.8%
Net Margin
CARE
CARE
CMCL
CMCL
Q4 25
Q3 25
13.9%
Q2 25
22.8%
Q1 25
24.2%
Q4 24
Q3 24
16.4%
7.0%
Q2 24
14.3%
20.3%
Q1 24
17.4%
5.4%
EPS (diluted)
CARE
CARE
CMCL
CMCL
Q4 25
$0.38
Q3 25
$0.24
Q2 25
$0.37
Q1 25
$0.39
Q4 24
$0.36
Q3 24
$0.24
$0.13
Q2 24
$0.21
$0.42
Q1 24
$0.25
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
CMCL
CMCL
Cash + ST InvestmentsLiquidity on hand
$7.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$419.7M
$231.0M
Total Assets
$4.9B
$339.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
CMCL
CMCL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$7.2M
Q2 24
$15.4M
Q1 24
$1.8M
Stockholders' Equity
CARE
CARE
CMCL
CMCL
Q4 25
$419.7M
Q3 25
$412.8M
Q2 25
$405.6M
Q1 25
$401.8M
Q4 24
$384.3M
Q3 24
$386.8M
$231.0M
Q2 24
$364.4M
$231.1M
Q1 24
$359.1M
$220.3M
Total Assets
CARE
CARE
CMCL
CMCL
Q4 25
$4.9B
Q3 25
$4.8B
Q2 25
$4.8B
Q1 25
$4.7B
Q4 24
$4.7B
Q3 24
$4.6B
$339.7M
Q2 24
$4.5B
$338.5M
Q1 24
$4.6B
$321.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
CMCL
CMCL
Operating Cash FlowLast quarter
$39.9M
$4.6M
Free Cash FlowOCF − Capex
$31.8M
FCF MarginFCF / Revenue
79.9%
Capex IntensityCapex / Revenue
20.2%
Cash ConversionOCF / Net Profit
1.40×
TTM Free Cash FlowTrailing 4 quarters
$54.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
CMCL
CMCL
Q4 25
$39.9M
Q3 25
$11.8M
Q2 25
$9.6M
Q1 25
$6.4M
Q4 24
$36.9M
Q3 24
$10.3M
$4.6M
Q2 24
$-2.5M
$19.1M
Q1 24
$17.6M
Free Cash Flow
CARE
CARE
CMCL
CMCL
Q4 25
$31.8M
Q3 25
$10.3M
Q2 25
$7.7M
Q1 25
$4.9M
Q4 24
$28.8M
Q3 24
$8.4M
Q2 24
$-4.3M
Q1 24
$16.3M
FCF Margin
CARE
CARE
CMCL
CMCL
Q4 25
79.9%
Q3 25
26.3%
Q2 25
20.6%
Q1 25
13.1%
Q4 24
83.5%
Q3 24
24.6%
Q2 24
-12.7%
Q1 24
48.8%
Capex Intensity
CARE
CARE
CMCL
CMCL
Q4 25
20.2%
Q3 25
3.9%
Q2 25
5.1%
Q1 25
4.1%
Q4 24
23.6%
Q3 24
5.5%
Q2 24
5.4%
Q1 24
3.9%
Cash Conversion
CARE
CARE
CMCL
CMCL
Q4 25
Q3 25
2.18×
Q2 25
1.13×
Q1 25
0.71×
Q4 24
Q3 24
1.83×
1.40×
Q2 24
-0.51×
1.87×
Q1 24
3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons